|
Volumn 57, Issue 8, 2007, Pages 419-420
|
Recommendations for the treatment of chronic Hepatitis C infection in children
a b c d e e |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALPHA INTERFERON;
INTERFERON;
PEGINTERFERON;
RIBAVIRIN;
THYROTROPIN;
ANTIVIRUS AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALOPECIA;
ARTICLE;
COMORBIDITY;
CONSENSUS;
DRUG CONTRAINDICATION;
DRUG DOSE REDUCTION;
DRUG TOLERABILITY;
FOLLOW UP;
GASTROENTEROLOGY;
HEMOGLOBINOPATHY;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERTHYROIDISM;
HYPOTHYROIDISM;
INFECTION PREVENTION;
IRON OVERLOAD;
KIDNEY FAILURE;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER FIBROSIS;
MEDICAL INFORMATION;
MEDICAL SPECIALIST;
NONALCOHOLIC FATTY LIVER;
PAKISTAN;
PEDIATRICS;
POLYMERASE CHAIN REACTION;
PREVALENCE;
RELAPSE;
TREATMENT DURATION;
TREATMENT INDICATION;
TREATMENT RESPONSE;
ADOLESCENT;
CHILD;
DRUG COMBINATION;
INFANT;
NEWBORN;
PRESCHOOL CHILD;
ADOLESCENT;
ANTIVIRAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
DRUG THERAPY, COMBINATION;
HEPATITIS C, CHRONIC;
HUMANS;
INFANT;
INFANT, NEWBORN;
INTERFERON-ALPHA;
RIBAVIRIN;
|
EID: 35348873627
PISSN: 00309982
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (4)
|